CONMED Corp — Director's Dealing 2021

Nov 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2021-11-04

Reporting Person: Pelletier Johonna Marie (Treasurer and VP, Tax)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-04	Common Stock	S	1247	$154.138	Disposed	2634	Direct
2021-11-04	Common Stock	M	5400	$78.76	Acquired	8034	Direct
2021-11-04	Common Stock	S	5400	$154.56	Disposed	2634	Direct
2021-11-04	Common Stock	M	2550	$97.69	Acquired	5184	Direct
2021-11-04	Common Stock	S	2550	$154.615	Disposed	2634	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-04	Options To Purchase Common Stock	$78.76	M	5400	Disposed	2029-03-01	Common Stock (5400)	Direct
2021-11-04	Options To Purchase Common Stock	$97.69	M	2550	Disposed	2030-03-02	Common Stock (2550)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.53 to $154.64. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period